(09) 535 7218 (Mon-Fri, 8.30-4.30)

Multi-Resistant UTI Funding

From 1 November 2024, fosfomycin (UroFos), will be funded in the community for urinary tract infections. 

POAC funding under this HealthPathway is no longer required.

 

This product has been added to your cart

CHECKOUT